Photometics is developing a cancer treatment using infrared light to perform “Selective Photo-Apoptosis” which triggers programmed cell death in cancer cells. Currently in Phase 1 trials, Photometics is initially targeting basal cell carcinoma, the world’s most common cancer.
Company’s Keywords:
<2
<1400000
<2009